nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—Mitomycin—urinary bladder cancer	0.202	0.323	CbGbCtD
Desloratadine—ABCB1—Gemcitabine—urinary bladder cancer	0.0581	0.093	CbGbCtD
Desloratadine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0568	0.0909	CbGbCtD
Desloratadine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0512	0.0819	CbGbCtD
Desloratadine—CYP1A2—Etoposide—urinary bladder cancer	0.0474	0.0759	CbGbCtD
Desloratadine—CYP2C9—Cisplatin—urinary bladder cancer	0.0435	0.0696	CbGbCtD
Desloratadine—ABCB1—Cisplatin—urinary bladder cancer	0.0422	0.0675	CbGbCtD
Desloratadine—ABCB1—Etoposide—urinary bladder cancer	0.0415	0.0664	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—urinary bladder cancer	0.0283	0.0453	CbGbCtD
Desloratadine—ABCB1—Methotrexate—urinary bladder cancer	0.0274	0.0439	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0266	0.0427	CbGbCtD
Desloratadine—CYP2C19—urine—urinary bladder cancer	0.00662	0.167	CbGeAlD
Desloratadine—CYP1A2—urine—urinary bladder cancer	0.00541	0.137	CbGeAlD
Desloratadine—CYP2C9—urine—urinary bladder cancer	0.00514	0.13	CbGeAlD
Desloratadine—CYP2D6—urine—urinary bladder cancer	0.00385	0.0973	CbGeAlD
Desloratadine—HRH1—prostate gland—urinary bladder cancer	0.00182	0.0459	CbGeAlD
Desloratadine—HRH1—epithelium—urinary bladder cancer	0.00134	0.0337	CbGeAlD
Desloratadine—CYP1A2—renal system—urinary bladder cancer	0.00132	0.0334	CbGeAlD
Desloratadine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00129	0.0325	CbGeAlD
Desloratadine—HRH1—urethra—urinary bladder cancer	0.00122	0.0307	CbGeAlD
Desloratadine—CYP2C19—vagina—urinary bladder cancer	0.00117	0.0296	CbGeAlD
Desloratadine—CYP2C9—female reproductive system—urinary bladder cancer	0.00101	0.0254	CbGeAlD
Desloratadine—ABCB1—prostate gland—urinary bladder cancer	0.000995	0.0251	CbGeAlD
Desloratadine—HRH1—female reproductive system—urinary bladder cancer	0.000993	0.0251	CbGeAlD
Desloratadine—CYP2D6—renal system—urinary bladder cancer	0.000943	0.0238	CbGeAlD
Desloratadine—HRH1—vagina—urinary bladder cancer	0.000898	0.0227	CbGeAlD
Desloratadine—ABCB1—seminal vesicle—urinary bladder cancer	0.000842	0.0212	CbGeAlD
Desloratadine—CYP2D6—female reproductive system—urinary bladder cancer	0.000755	0.0191	CbGeAlD
Desloratadine—ABCB1—epithelium—urinary bladder cancer	0.000731	0.0185	CbGeAlD
Desloratadine—ABCB1—renal system—urinary bladder cancer	0.000678	0.0171	CbGeAlD
Desloratadine—Fatigue—Thiotepa—urinary bladder cancer	0.000677	0.00283	CcSEcCtD
Desloratadine—ABCB1—urethra—urinary bladder cancer	0.000666	0.0168	CbGeAlD
Desloratadine—Oedema—Gemcitabine—urinary bladder cancer	0.000661	0.00276	CcSEcCtD
Desloratadine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000661	0.00276	CcSEcCtD
Desloratadine—Infection—Gemcitabine—urinary bladder cancer	0.000657	0.00274	CcSEcCtD
Desloratadine—Irritability—Methotrexate—urinary bladder cancer	0.000656	0.00274	CcSEcCtD
Desloratadine—Convulsion—Cisplatin—urinary bladder cancer	0.000654	0.00273	CcSEcCtD
Desloratadine—Mood swings—Methotrexate—urinary bladder cancer	0.000652	0.00272	CcSEcCtD
Desloratadine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00065	0.00271	CcSEcCtD
Desloratadine—Oedema—Fluorouracil—urinary bladder cancer	0.00065	0.00271	CcSEcCtD
Desloratadine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000648	0.00271	CcSEcCtD
Desloratadine—Infection—Fluorouracil—urinary bladder cancer	0.000646	0.0027	CcSEcCtD
Desloratadine—Myalgia—Cisplatin—urinary bladder cancer	0.000643	0.00268	CcSEcCtD
Desloratadine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000642	0.00268	CcSEcCtD
Desloratadine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000637	0.00266	CcSEcCtD
Desloratadine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000634	0.00265	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—urinary bladder cancer	0.000634	0.00265	CcSEcCtD
Desloratadine—Affect lability—Epirubicin—urinary bladder cancer	0.000634	0.00265	CcSEcCtD
Desloratadine—Anorexia—Gemcitabine—urinary bladder cancer	0.00063	0.00263	CcSEcCtD
Desloratadine—Urticaria—Thiotepa—urinary bladder cancer	0.000624	0.00261	CcSEcCtD
Desloratadine—Breast disorder—Methotrexate—urinary bladder cancer	0.000622	0.0026	CcSEcCtD
Desloratadine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000621	0.00259	CcSEcCtD
Desloratadine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000621	0.00259	CcSEcCtD
Desloratadine—Anorexia—Fluorouracil—urinary bladder cancer	0.000619	0.00259	CcSEcCtD
Desloratadine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000616	0.00257	CcSEcCtD
Desloratadine—Oedema—Cisplatin—urinary bladder cancer	0.000616	0.00257	CcSEcCtD
Desloratadine—Infection—Cisplatin—urinary bladder cancer	0.000612	0.00256	CcSEcCtD
Desloratadine—Mood swings—Epirubicin—urinary bladder cancer	0.00061	0.00255	CcSEcCtD
Desloratadine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000604	0.00252	CcSEcCtD
Desloratadine—Cough—Etoposide—urinary bladder cancer	0.000603	0.00252	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000602	0.00251	CcSEcCtD
Desloratadine—Tachycardia—Cisplatin—urinary bladder cancer	0.000601	0.00251	CcSEcCtD
Desloratadine—Convulsion—Etoposide—urinary bladder cancer	0.000599	0.0025	CcSEcCtD
Desloratadine—Insomnia—Gemcitabine—urinary bladder cancer	0.000598	0.0025	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000592	0.00247	CcSEcCtD
Desloratadine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000589	0.00246	CcSEcCtD
Desloratadine—Insomnia—Fluorouracil—urinary bladder cancer	0.000588	0.00245	CcSEcCtD
Desloratadine—Somnolence—Gemcitabine—urinary bladder cancer	0.000588	0.00245	CcSEcCtD
Desloratadine—Anorexia—Cisplatin—urinary bladder cancer	0.000587	0.00245	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—urinary bladder cancer	0.000586	0.00245	CcSEcCtD
Desloratadine—Breast disorder—Epirubicin—urinary bladder cancer	0.000582	0.00243	CcSEcCtD
Desloratadine—HRH1—lymph node—urinary bladder cancer	0.000581	0.0147	CbGeAlD
Desloratadine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000579	0.00242	CcSEcCtD
Desloratadine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000579	0.00242	CcSEcCtD
Desloratadine—Somnolence—Fluorouracil—urinary bladder cancer	0.000578	0.00241	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000576	0.0024	CcSEcCtD
Desloratadine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000575	0.0024	CcSEcCtD
Desloratadine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000572	0.00239	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000571	0.00238	CcSEcCtD
Desloratadine—Fatigue—Gemcitabine—urinary bladder cancer	0.00057	0.00238	CcSEcCtD
Desloratadine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000565	0.00236	CcSEcCtD
Desloratadine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000564	0.00236	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—urinary bladder cancer	0.000564	0.00236	CcSEcCtD
Desloratadine—Asthenia—Thiotepa—urinary bladder cancer	0.000564	0.00235	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000561	0.00234	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000561	0.00234	CcSEcCtD
Desloratadine—Infection—Etoposide—urinary bladder cancer	0.000561	0.00234	CcSEcCtD
Desloratadine—Pruritus—Thiotepa—urinary bladder cancer	0.000556	0.00232	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000552	0.00231	CcSEcCtD
Desloratadine—Tachycardia—Etoposide—urinary bladder cancer	0.000551	0.0023	CcSEcCtD
Desloratadine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000549	0.00229	CcSEcCtD
Desloratadine—ABCB1—female reproductive system—urinary bladder cancer	0.000543	0.0137	CbGeAlD
Desloratadine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000538	0.00225	CcSEcCtD
Desloratadine—Anorexia—Etoposide—urinary bladder cancer	0.000538	0.00225	CcSEcCtD
Desloratadine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000538	0.00224	CcSEcCtD
Desloratadine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000536	0.00224	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—urinary bladder cancer	0.000535	0.00223	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000533	0.00222	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000532	0.00222	CcSEcCtD
Desloratadine—Infestation—Methotrexate—urinary bladder cancer	0.00053	0.00221	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—urinary bladder cancer	0.00053	0.00221	CcSEcCtD
Desloratadine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000522	0.00218	CcSEcCtD
Desloratadine—Dizziness—Thiotepa—urinary bladder cancer	0.00052	0.00217	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000517	0.00216	CcSEcCtD
Desloratadine—Urticaria—Fluorouracil—urinary bladder cancer	0.000516	0.00216	CcSEcCtD
Desloratadine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000514	0.00214	CcSEcCtD
Desloratadine—Dyspnoea—Etoposide—urinary bladder cancer	0.000503	0.0021	CcSEcCtD
Desloratadine—Somnolence—Etoposide—urinary bladder cancer	0.000502	0.00209	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000501	0.00209	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—urinary bladder cancer	0.0005	0.00209	CcSEcCtD
Desloratadine—Vomiting—Thiotepa—urinary bladder cancer	0.0005	0.00209	CcSEcCtD
Desloratadine—Infestation—Epirubicin—urinary bladder cancer	0.000496	0.00207	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—urinary bladder cancer	0.000496	0.00207	CcSEcCtD
Desloratadine—Rash—Thiotepa—urinary bladder cancer	0.000495	0.00207	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—urinary bladder cancer	0.000495	0.00207	CcSEcCtD
Desloratadine—Dermatitis—Thiotepa—urinary bladder cancer	0.000495	0.00207	CcSEcCtD
Desloratadine—Headache—Thiotepa—urinary bladder cancer	0.000492	0.00206	CcSEcCtD
Desloratadine—ABCB1—vagina—urinary bladder cancer	0.000491	0.0124	CbGeAlD
Desloratadine—Decreased appetite—Etoposide—urinary bladder cancer	0.000491	0.00205	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000487	0.00203	CcSEcCtD
Desloratadine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000487	0.00203	CcSEcCtD
Desloratadine—Fatigue—Etoposide—urinary bladder cancer	0.000487	0.00203	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000482	0.00201	CcSEcCtD
Desloratadine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000479	0.002	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000478	0.002	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—urinary bladder cancer	0.000476	0.00199	CcSEcCtD
Desloratadine—Asthenia—Gemcitabine—urinary bladder cancer	0.000474	0.00198	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000472	0.00197	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000469	0.00196	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—urinary bladder cancer	0.000468	0.00195	CcSEcCtD
Desloratadine—Pruritus—Gemcitabine—urinary bladder cancer	0.000468	0.00195	CcSEcCtD
Desloratadine—Nausea—Thiotepa—urinary bladder cancer	0.000467	0.00195	CcSEcCtD
Desloratadine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000461	0.00193	CcSEcCtD
Desloratadine—Pruritus—Fluorouracil—urinary bladder cancer	0.00046	0.00192	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000459	0.00192	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—urinary bladder cancer	0.000459	0.00192	CcSEcCtD
Desloratadine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000454	0.0019	CcSEcCtD
Desloratadine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000452	0.00189	CcSEcCtD
Desloratadine—Urticaria—Etoposide—urinary bladder cancer	0.000448	0.00187	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—urinary bladder cancer	0.000446	0.00186	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—urinary bladder cancer	0.000446	0.00186	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000446	0.00186	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—urinary bladder cancer	0.000445	0.00186	CcSEcCtD
Desloratadine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000445	0.00186	CcSEcCtD
Desloratadine—Asthenia—Cisplatin—urinary bladder cancer	0.000442	0.00185	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000442	0.00185	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000442	0.00184	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000438	0.00183	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000434	0.00181	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000433	0.00181	CcSEcCtD
Desloratadine—Dizziness—Fluorouracil—urinary bladder cancer	0.00043	0.00179	CcSEcCtD
Desloratadine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000421	0.00176	CcSEcCtD
Desloratadine—Vomiting—Gemcitabine—urinary bladder cancer	0.00042	0.00175	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—urinary bladder cancer	0.000417	0.00174	CcSEcCtD
Desloratadine—Rash—Gemcitabine—urinary bladder cancer	0.000417	0.00174	CcSEcCtD
Desloratadine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000416	0.00174	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000416	0.00174	CcSEcCtD
Desloratadine—Erythema—Methotrexate—urinary bladder cancer	0.000414	0.00173	CcSEcCtD
Desloratadine—Headache—Gemcitabine—urinary bladder cancer	0.000414	0.00173	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000413	0.00173	CcSEcCtD
Desloratadine—Vomiting—Fluorouracil—urinary bladder cancer	0.000413	0.00173	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000412	0.00172	CcSEcCtD
Desloratadine—Rash—Fluorouracil—urinary bladder cancer	0.00041	0.00171	CcSEcCtD
Desloratadine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000409	0.00171	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000409	0.00171	CcSEcCtD
Desloratadine—Headache—Fluorouracil—urinary bladder cancer	0.000407	0.0017	CcSEcCtD
Desloratadine—Asthenia—Etoposide—urinary bladder cancer	0.000405	0.00169	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000405	0.00169	CcSEcCtD
Desloratadine—Pruritus—Etoposide—urinary bladder cancer	0.000399	0.00167	CcSEcCtD
Desloratadine—Nausea—Gemcitabine—urinary bladder cancer	0.000393	0.00164	CcSEcCtD
Desloratadine—Vomiting—Cisplatin—urinary bladder cancer	0.000392	0.00164	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—urinary bladder cancer	0.00039	0.00163	CcSEcCtD
Desloratadine—Rash—Cisplatin—urinary bladder cancer	0.000388	0.00162	CcSEcCtD
Desloratadine—Dermatitis—Cisplatin—urinary bladder cancer	0.000388	0.00162	CcSEcCtD
Desloratadine—Erythema—Epirubicin—urinary bladder cancer	0.000388	0.00162	CcSEcCtD
Desloratadine—Diarrhoea—Etoposide—urinary bladder cancer	0.000386	0.00161	CcSEcCtD
Desloratadine—Nausea—Fluorouracil—urinary bladder cancer	0.000386	0.00161	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000382	0.0016	CcSEcCtD
Desloratadine—Dizziness—Etoposide—urinary bladder cancer	0.000373	0.00156	CcSEcCtD
Desloratadine—Nausea—Cisplatin—urinary bladder cancer	0.000366	0.00153	CcSEcCtD
Desloratadine—Cough—Methotrexate—urinary bladder cancer	0.000361	0.00151	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000361	0.00151	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—urinary bladder cancer	0.000359	0.0015	CcSEcCtD
Desloratadine—Vomiting—Etoposide—urinary bladder cancer	0.000359	0.0015	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—urinary bladder cancer	0.000359	0.0015	CcSEcCtD
Desloratadine—Agitation—Epirubicin—urinary bladder cancer	0.000356	0.00149	CcSEcCtD
Desloratadine—Rash—Etoposide—urinary bladder cancer	0.000356	0.00149	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—urinary bladder cancer	0.000356	0.00148	CcSEcCtD
Desloratadine—Headache—Etoposide—urinary bladder cancer	0.000354	0.00148	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—urinary bladder cancer	0.000353	0.00147	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—urinary bladder cancer	0.000343	0.00143	CcSEcCtD
Desloratadine—Cough—Epirubicin—urinary bladder cancer	0.000338	0.00141	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000338	0.00141	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—urinary bladder cancer	0.000336	0.0014	CcSEcCtD
Desloratadine—Infection—Methotrexate—urinary bladder cancer	0.000336	0.0014	CcSEcCtD
Desloratadine—Nausea—Etoposide—urinary bladder cancer	0.000335	0.0014	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000332	0.00138	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—urinary bladder cancer	0.00033	0.00138	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—urinary bladder cancer	0.00033	0.00138	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—urinary bladder cancer	0.000323	0.00135	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—urinary bladder cancer	0.000322	0.00135	CcSEcCtD
Desloratadine—ABCB1—lymph node—urinary bladder cancer	0.000318	0.00802	CbGeAlD
Desloratadine—Palpitations—Doxorubicin—urinary bladder cancer	0.000317	0.00132	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000316	0.00132	CcSEcCtD
Desloratadine—Oedema—Epirubicin—urinary bladder cancer	0.000316	0.00132	CcSEcCtD
Desloratadine—Infection—Epirubicin—urinary bladder cancer	0.000314	0.00131	CcSEcCtD
Desloratadine—Cough—Doxorubicin—urinary bladder cancer	0.000313	0.00131	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—urinary bladder cancer	0.000311	0.0013	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00031	0.0013	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—urinary bladder cancer	0.000309	0.00129	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000308	0.00129	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—urinary bladder cancer	0.000306	0.00128	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—urinary bladder cancer	0.000305	0.00127	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—urinary bladder cancer	0.000302	0.00126	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000301	0.00126	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—urinary bladder cancer	0.000301	0.00125	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000299	0.00125	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000298	0.00124	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000294	0.00123	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000293	0.00122	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—urinary bladder cancer	0.000293	0.00122	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000292	0.00122	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—urinary bladder cancer	0.000291	0.00122	CcSEcCtD
Desloratadine—Infection—Doxorubicin—urinary bladder cancer	0.000291	0.00121	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000288	0.0012	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000287	0.0012	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—urinary bladder cancer	0.000286	0.00119	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000286	0.00119	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000282	0.00118	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—urinary bladder cancer	0.000281	0.00117	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—urinary bladder cancer	0.000279	0.00116	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000278	0.00116	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000276	0.00115	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000275	0.00115	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000273	0.00114	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—urinary bladder cancer	0.000273	0.00114	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—urinary bladder cancer	0.000269	0.00112	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000267	0.00112	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000267	0.00112	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000267	0.00111	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—urinary bladder cancer	0.000265	0.00111	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000261	0.00109	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—urinary bladder cancer	0.00026	0.00109	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000259	0.00108	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000258	0.00108	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000254	0.00106	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000253	0.00106	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—urinary bladder cancer	0.000252	0.00105	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—urinary bladder cancer	0.000251	0.00105	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00025	0.00104	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00025	0.00104	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000249	0.00104	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—urinary bladder cancer	0.000243	0.00101	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000239	0.000999	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—urinary bladder cancer	0.000239	0.000999	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000233	0.000973	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—urinary bladder cancer	0.000233	0.000971	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000231	0.000966	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000231	0.000966	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000231	0.000966	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—urinary bladder cancer	0.000227	0.000948	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—urinary bladder cancer	0.000224	0.000935	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—urinary bladder cancer	0.000224	0.000933	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000216	0.000904	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000216	0.0009	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—urinary bladder cancer	0.000215	0.000897	CcSEcCtD
Desloratadine—Rash—Methotrexate—urinary bladder cancer	0.000213	0.00089	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—urinary bladder cancer	0.000213	0.000889	CcSEcCtD
Desloratadine—Headache—Methotrexate—urinary bladder cancer	0.000212	0.000884	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—urinary bladder cancer	0.00021	0.000877	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—urinary bladder cancer	0.000209	0.000873	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—urinary bladder cancer	0.000207	0.000865	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—urinary bladder cancer	0.000201	0.00084	CcSEcCtD
Desloratadine—Nausea—Methotrexate—urinary bladder cancer	0.000201	0.000838	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.0002	0.000836	CcSEcCtD
Desloratadine—Rash—Epirubicin—urinary bladder cancer	0.000199	0.000833	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—urinary bladder cancer	0.000199	0.000832	CcSEcCtD
Desloratadine—Headache—Epirubicin—urinary bladder cancer	0.000198	0.000827	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—urinary bladder cancer	0.000194	0.000808	CcSEcCtD
Desloratadine—Nausea—Epirubicin—urinary bladder cancer	0.000188	0.000785	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—urinary bladder cancer	0.000186	0.000777	CcSEcCtD
Desloratadine—Rash—Doxorubicin—urinary bladder cancer	0.000185	0.000771	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000184	0.00077	CcSEcCtD
Desloratadine—Headache—Doxorubicin—urinary bladder cancer	0.000183	0.000766	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—urinary bladder cancer	0.000174	0.000726	CcSEcCtD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000131	0.00136	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000129	0.00134	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000129	0.00134	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000125	0.0013	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000125	0.0013	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000123	0.00128	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000123	0.00128	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000122	0.00127	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000122	0.00127	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000121	0.00126	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000121	0.00126	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000121	0.00126	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00012	0.00125	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000117	0.00121	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000116	0.00121	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000113	0.00118	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000113	0.00117	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000112	0.00117	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000112	0.00116	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000112	0.00116	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000111	0.00116	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000111	0.00116	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00011	0.00115	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.00011	0.00114	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.00011	0.00114	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000104	0.00109	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000104	0.00109	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000104	0.00108	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000104	0.00108	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000102	0.00107	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.86e-05	0.00103	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	9.55e-05	0.000994	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.51e-05	0.00099	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.42e-05	0.00098	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.8e-05	0.000916	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.71e-05	0.000907	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.68e-05	0.000903	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.64e-05	0.000899	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	8.48e-05	0.000883	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	8.17e-05	0.00085	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	7.97e-05	0.00083	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	7.74e-05	0.000806	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	7.74e-05	0.000806	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.62e-05	0.000793	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.57e-05	0.000788	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	7.56e-05	0.000787	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NAT1—urinary bladder cancer	7.56e-05	0.000787	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	7.51e-05	0.000782	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.48e-05	0.000778	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	7.45e-05	0.000775	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HDAC4—urinary bladder cancer	7.25e-05	0.000754	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	7.12e-05	0.000741	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	7.12e-05	0.000741	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	7.08e-05	0.000737	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	7.06e-05	0.000735	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	7.06e-05	0.000735	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.95e-05	0.000723	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.91e-05	0.00072	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	6.52e-05	0.000678	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	6.46e-05	0.000672	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	6.43e-05	0.000669	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.43e-05	0.000669	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	6.38e-05	0.000664	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	6.37e-05	0.000663	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	6.34e-05	0.00066	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.34e-05	0.00066	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	6.23e-05	0.000648	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	6.2e-05	0.000645	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GLI1—urinary bladder cancer	6.07e-05	0.000632	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	6.03e-05	0.000628	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	6.03e-05	0.000628	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	6.02e-05	0.000627	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	5.99e-05	0.000624	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.94e-05	0.000618	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.88e-05	0.000612	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	5.87e-05	0.000611	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.87e-05	0.000611	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.82e-05	0.000605	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.73e-05	0.000596	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.6e-05	0.000583	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	5.54e-05	0.000577	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.52e-05	0.000574	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.49e-05	0.000572	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.42e-05	0.000564	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.41e-05	0.000563	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	5.4e-05	0.000562	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.35e-05	0.000557	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.16e-05	0.000537	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	5.09e-05	0.00053	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.02e-05	0.000522	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.97e-05	0.000517	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—CXCL8—urinary bladder cancer	4.89e-05	0.000509	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.71e-05	0.00049	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.69e-05	0.000488	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.69e-05	0.000488	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.58e-05	0.000477	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.57e-05	0.000476	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.51e-05	0.000469	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.49e-05	0.000468	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.4e-05	0.000458	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.32e-05	0.000449	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.29e-05	0.000447	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.28e-05	0.000445	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	4.24e-05	0.000442	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.19e-05	0.000436	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RBX1—urinary bladder cancer	4.16e-05	0.000433	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.15e-05	0.000432	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.14e-05	0.000431	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.11e-05	0.000428	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TSC1—urinary bladder cancer	3.91e-05	0.000407	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.9e-05	0.000406	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.87e-05	0.000403	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JAG1—urinary bladder cancer	3.73e-05	0.000388	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.69e-05	0.000384	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.67e-05	0.000382	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.66e-05	0.000381	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.66e-05	0.000381	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.58e-05	0.000372	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.51e-05	0.000365	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.39e-05	0.000353	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.39e-05	0.000353	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.37e-05	0.000351	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.37e-05	0.000351	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.34e-05	0.000348	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.31e-05	0.000345	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.31e-05	0.000345	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.31e-05	0.000344	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.29e-05	0.000342	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.24e-05	0.000337	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.21e-05	0.000334	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—RHOA—urinary bladder cancer	3.15e-05	0.000328	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.12e-05	0.000325	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.12e-05	0.000325	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.09e-05	0.000322	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.09e-05	0.000322	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.08e-05	0.00032	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.03e-05	0.000315	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—S100B—urinary bladder cancer	3.02e-05	0.000314	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.01e-05	0.000313	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3e-05	0.000312	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.95e-05	0.000307	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—RHOA—urinary bladder cancer	2.86e-05	0.000298	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.85e-05	0.000297	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.77e-05	0.000288	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.73e-05	0.000285	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	2.71e-05	0.000282	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.67e-05	0.000278	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.65e-05	0.000276	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.64e-05	0.000275	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.64e-05	0.000275	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	2.64e-05	0.000275	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.63e-05	0.000273	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.56e-05	0.000267	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.52e-05	0.000263	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.52e-05	0.000262	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.51e-05	0.000261	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.49e-05	0.000259	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.42e-05	0.000252	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	2.4e-05	0.00025	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	2.39e-05	0.000249	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.31e-05	0.000241	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.28e-05	0.000237	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.23e-05	0.000232	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.21e-05	0.00023	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	2.19e-05	0.000228	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	2.13e-05	0.000222	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.13e-05	0.000222	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.12e-05	0.000221	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.11e-05	0.00022	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.1e-05	0.000218	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.1e-05	0.000218	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.1e-05	0.000218	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.08e-05	0.000216	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.07e-05	0.000215	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.07e-05	0.000215	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.05e-05	0.000213	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.05e-05	0.000213	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.01e-05	0.000209	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.000209	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.97e-05	0.000205	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.96e-05	0.000204	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.95e-05	0.000203	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.93e-05	0.000201	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.93e-05	0.000201	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.93e-05	0.000201	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.92e-05	0.0002	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.91e-05	0.000199	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.91e-05	0.000199	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	1.87e-05	0.000194	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	0.000193	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.85e-05	0.000192	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	1.84e-05	0.000192	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	1.84e-05	0.000191	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.83e-05	0.00019	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.81e-05	0.000189	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.81e-05	0.000188	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.8e-05	0.000188	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	0.000187	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.78e-05	0.000185	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	1.73e-05	0.00018	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.72e-05	0.000179	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.7e-05	0.000177	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	1.69e-05	0.000176	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.69e-05	0.000176	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.65e-05	0.000172	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.63e-05	0.00017	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.63e-05	0.00017	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	1.56e-05	0.000163	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.56e-05	0.000163	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.54e-05	0.00016	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.5e-05	0.000156	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	1.48e-05	0.000154	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	1.47e-05	0.000153	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.47e-05	0.000153	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.44e-05	0.00015	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.00015	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	1.42e-05	0.000148	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.41e-05	0.000147	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	1.38e-05	0.000144	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.38e-05	0.000144	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.37e-05	0.000143	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	1.34e-05	0.00014	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.34e-05	0.000139	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.33e-05	0.000139	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.33e-05	0.000138	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	0.000137	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.27e-05	0.000132	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.24e-05	0.000129	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000123	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.17e-05	0.000122	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.15e-05	0.00012	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.12e-05	0.000117	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	1.11e-05	0.000115	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	0.000113	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	1.08e-05	0.000113	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	0.000112	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.000107	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	1.02e-05	0.000107	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.01e-05	0.000105	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—EP300—urinary bladder cancer	9.83e-06	0.000102	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—EP300—urinary bladder cancer	9.59e-06	9.98e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	9.48e-06	9.86e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	9.4e-06	9.78e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	9.21e-06	9.58e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	9.1e-06	9.47e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—EP300—urinary bladder cancer	9.04e-06	9.41e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.96e-06	9.33e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	8.71e-06	9.06e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	8.03e-06	8.36e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.66e-06	7.97e-05	CbGpPWpGaD
